How Rising Hematological Malignancies and Advanced Therapy Investments Are Driving the Germany Car T Cell Therapy Market
The Germany Car T Cell Therapy market is expanding as healthcare providers, pharmaceutical companies, and research institutions invest in advanced cellular therapies to address the rising incidence of hematological malignancies and improve patient outcomes. The market was valued at USD 692.85 million in 2024 and is projected to reach USD 3,374.8 million by 2035, growing at a CAGR of 15.48%. The...
0 Commentarios 0 Acciones 215 Views 0 Vista previa